Literature DB >> 8390753

Immunological characterization of the VSV nucleocapsid (N) protein expressed by recombinant baculovirus in Spodoptera exigua larva: use in differential diagnosis between vaccinated and infected animals.

S Ahmad1, M Bassiri, A K Banerjee, T Yilma.   

Abstract

Vesicular stomatitis is a viral disease of cattle, pigs, and horses. The disease is characterized by vesicular lesions on the epithelium of the mouth, feet, and teats. The pathological lesions are virtually indistinguishable from that of foot-and-mouth disease. We have developed a recombinant baculovirus that expresses the nucleocapsid (N) protein of the New Jersey serotype of vesicular stomatitis virus (VSVNJ) in insect cells (Sf9) and larvae (Spodoptera exigua). The gene was expressed under control of the polyhedrin promoter as a fusion or nonfusion protein. The recombinant N protein expressed in insect cells could not be distinguished from N protein produced in VSVNJ-infected CHO cells by immunological and biochemical analyses. The level of expression of N as a percentage of the total protein in Sf9 cells was 41% for the fusion and 60% for the nonfusion protein. Higher level (68%) of expression of the nonfusion N protein was obtained in larvae. Recombinant N protein was used in an ELISA to distinguish animals vaccinated with a recombinant VSV glycoprotein from those exposed to the whole virus by infection or classical vaccine. Lysate of a single infected larva (0.2-0.3 g) was adequate for coating ELISA plates to perform 10,000 serum assays in duplicate.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8390753     DOI: 10.1006/viro.1993.1023

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  Purification and characterization of Nipah virus nucleocapsid protein produced in insect cells.

Authors:  Majid Eshaghi; Wen Siang Tan; Swee Tin Ong; Khatijah Yusoff
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

2.  Immunization with live attenuated simian immunodeficiency virus induces strong type 1 T helper responses and beta-chemokine production.

Authors:  M C Gauduin; R L Glickman; S Ahmad; T Yilma; R P Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

3.  Newcastle disease virus (NDV) marker vaccine: an immunodominant epitope on the nucleoprotein gene of NDV can be deleted or replaced by a foreign epitope.

Authors:  Teshome Mebatsion; Marck J M Koolen; Leonie T C de Vaan; Niels de Haas; Marian Braber; Angela Römer-Oberdörfer; Paul van den Elzen; Pieter van der Marel
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

4.  Reliable confirmation of antibodies to bovine respiratory syncytial virus (BRSV) by enzyme-linked immunosorbent assay using BRSV nucleocapsid protein expressed in insect cells.

Authors:  S K Samal; M K Pastey; T McPhillips; D K Carmel; S B Mohanty
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

5.  Enzyme-linked immunosorbent assay using glycoprotein and monoclonal antibody for detecting antibodies to vesicular stomatitis virus serotype New Jersey.

Authors:  Hyang-Sim Lee; Eun-Jeong Heo; Hye-Young Jeoung; Hyo-Rim Ko; Chang-Hee Kweon; Hee-Jeong Youn; Young-Joon Ko
Journal:  Clin Vaccine Immunol       Date:  2009-03-11

6.  Seroprevalence of turkey coronavirus in North American turkeys determined by a newly developed enzyme-linked immunosorbent assay based on recombinant antigen.

Authors:  Maged H Gomaa; Dongwan Yoo; Davor Ojkic; John R Barta
Journal:  Clin Vaccine Immunol       Date:  2008-10-29

7.  Recombinant nucleocapsid protein is potentially an inexpensive, effective serodiagnostic reagent for infectious bronchitis virus.

Authors:  A Ndifuna; A K Waters; M Zhou; E W Collisson
Journal:  J Virol Methods       Date:  1998-01       Impact factor: 2.014

Review 8.  Vaccines for viral and parasitic diseases produced with baculovirus vectors.

Authors:  Monique M van Oers
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

9.  Rescue of a chimeric rinderpest virus with the nucleocapsid protein derived from peste-des-petits-ruminants virus: use as a marker vaccine.

Authors:  Satya Parida; Madhuchhanda Mahapatra; Sai Kumar; Subash C Das; Michael D Baron; John Anderson; Thomas Barrett
Journal:  J Gen Virol       Date:  2007-07       Impact factor: 3.891

10.  Expression and purification of turkey coronavirus nucleocapsid protein in Escherichia coli.

Authors:  C C Loa; T L Lin; C C Wu; T A Bryan; T Hooper; D Schrader
Journal:  J Virol Methods       Date:  2004-03-15       Impact factor: 2.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.